Acute cholecystitis medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 75: | Line 75: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category: Gastroenterology]] |
Revision as of 18:18, 18 December 2017
Acute cholecystitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acute cholecystitis medical therapy On the Web |
American Roentgen Ray Society Images of Acute cholecystitis medical therapy |
Risk calculators and risk factors for Acute cholecystitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Overview
The mainstay of treatment for acute cholecystitis (calculous and acalculous) is surgery. Pharmacologic medical therapy is recommended for cases of acute cholecystitis in which surgery is delayed. Empiric pharmacologic medical therapies for acute cholecystitis include either amoxicillin-clavulanic acid, cefoxitin, cefotaxime, or ceftriaxone with metronidazole, and ciprofloxacin or levofloxacin with metronidazole.
Medical Therapy
- Pharmacologic medical therapy is recommended for cases of acute cholecystitis (calculous and acalculous) in which surgery is delayed and in complicated cases.[1][2][3][4][5]
- Empiric pharmacologic medical therapies for acute cholecystitis include either amoxicillin-clavulanic acid, cefoxitin, cefotaxime, or ceftriaxone with metronidazole, and ciprofloxacin or levofloxacin with metronidazole.
- Empirically administered antimicrobial drugs should be changed for more appropriate agents, according to the identified causative microorganisms and their susceptibility testing results.
- Antibiotics are not indicated for the conservative management of acute calculous cholecystitis or in patients scheduled for cholecystectomy.[6]
Acute cholecystitis
- 1 Stage 1 - Mild (grade I) acute cholecystitis
- 1.1 Adult
- Oral regimens:
- Preferred regimen (1): Ampicillin/sulbactam
- Preferred regimen (2): Ciprofloxacin
- Preferred regimen (3): Levofloxacin
- Alternative regimen (1): Cefazolin
- Alternative regimen (2): Cefotiam
- Oral regimens:
- 1.1 Adult
- 2 Stage 2 - Moderate (grade II) and severe (grade III) acute cholecystitis
- 2.1 Adult
- Preferred regimen (1): Piperacillin/tazobactam 3.375 or 4.5 g IV q6h
- Preferred regimen (2): Ampicillin/sulbactam 3 g IV q6h
- Preferred regimen (3): Ceftriaxone 1 g IV q24h or 2 g IV q12h for CNS infections
- Alternative regimen (3): Levofloxacin plus metronidazole 500 or 750 mg IV q24h plus 500 mg IV q8h
- Alternative regimen (3): Ciprofloxacin plus metronidazole 400mg IV q24h plus 500 mg IV q8h
- Alternative regimen (3): Meropenem 1mg IV q6h
- Alternative regimen (3): Imipenem 500mg IV q6h
- 2.1 Adult
Add metronidazole to the preferred regimen (1), (2), and (3) if anaerobic bacteria are suspected.
Recommendations of Infectious Diseases Society of America
Infectious Diseases Society of America recommends the following antibiotic regimens for patients with acute cholecystitis:[7]
^ Because of increasing resistance of Escherichia coli to fluoroquinolones, local population susceptibility profiles and, if available, isolate susceptibility should be reviewed. Adopted from Journal of Hepato-Biliary-Pancreatic Sciences |
Duration of therapy
- The duration of the antibiotic in acute cholecystitis depends on the severity of the disease.[8][9][10]
- Antibiotic therapy should be discontinued within 24 hours of cholecystectomy for mild cholecystitis unless there is evidence of infection extending outside of the gallbladder.
- Antibiotic therapy is discontinued within 4-7 days for moderate-severe cholecystitis.
- In the cases of bacteremia with gram-positive bacteria known to cause infective endocarditis (eg, Enterococcus and Streptococcus), consider continuing antibiotics for 14 days.
References
- ↑ Yoshida M, Takada T, Kawarada Y, Tanaka A, Nimura Y, Gomi H, Hirota M, Miura F, Wada K, Mayumi T, Solomkin JS, Strasberg S, Pitt HA, Belghiti J, de Santibanes E, Fan ST, Chen MF, Belli G, Hilvano SC, Kim SW, Ker CG (2007). "Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 83–90. doi:10.1007/s00534-006-1160-y. PMC 2784497. PMID 17252301.
- ↑ "Cholecystitis - ScienceDirect".
- ↑ Yokoe M, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Gomi H, Pitt HA, Garden OJ, Kiriyama S, Hata J, Gabata T, Yoshida M, Miura F, Okamoto K, Tsuyuguchi T, Itoi T, Yamashita Y, Dervenis C, Chan AC, Lau WY, Supe AN, Belli G, Hilvano SC, Liau KH, Kim MH, Kim SW, Ker CG (2013). "TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos)". J Hepatobiliary Pancreat Sci. 20 (1): 35–46. doi:10.1007/s00534-012-0568-9. PMID 23340953.
- ↑ Bornscheuer T, Schmiedel S (2014). "Calculated Antibiosis of Acute Cholangitis and Cholecystitis". Viszeralmedizin. 30 (5): 297–302. doi:10.1159/000368335. PMC 4571718. PMID 26535043.
- ↑ Loozen CS, Oor JE, van Ramshorst B, van Santvoort HC, Boerma D (2017). "Conservative treatment of acute cholecystitis: a systematic review and pooled analysis". Surg Endosc. 31 (2): 504–515. doi:10.1007/s00464-016-5011-x. PMID 27317033.
- ↑ "Systematic review of antibiotic treatment for acute calculous cholecystitis - van Dijk - 2016 - BJS - Wiley Online Library".
- ↑ Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG (2010). "Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America". Clin. Infect. Dis. 50 (2): 133–64. doi:10.1086/649554. PMID 20034345.
- ↑ Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG (2010). "Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America". Surg Infect (Larchmt). 11 (1): 79–109. doi:10.1089/sur.2009.9930. PMID 20163262.
- ↑ Hoffmann C, Zak M, Avery L, Brown J (2016). "Treatment Modalities and Antimicrobial Stewardship Initiatives in the Management of Intra-Abdominal Infections". Antibiotics (Basel). 5 (1). doi:10.3390/antibiotics5010011. PMC 4810413. PMID 27025526.
- ↑ Gomi H, Solomkin JS, Takada T, Strasberg SM, Pitt HA, Yoshida M, Kusachi S, Mayumi T, Miura F, Kiriyama S, Yokoe M, Kimura Y, Higuchi R, Windsor JA, Dervenis C, Liau KH, Kim MH (2013). "TG13 antimicrobial therapy for acute cholangitis and cholecystitis". J Hepatobiliary Pancreat Sci. 20 (1): 60–70. doi:10.1007/s00534-012-0572-0. PMID 23340954.